AMA Publishing Group: Allergy/Immunology Topic Collectionhttp://pubs.jamanetwork.com/
en-usWed, 08 Apr 2015 00:00:00 GMTWed, 08 Apr 2015 11:44:28 GMTSilverchaireditor@pubs.jamanetwork.comwebmaster@pubs.jamanetwork.comAre Anti-inflammatory Therapies Viable Treatments for Psychiatric Disorders? Where the Rubber Meets the Road http://pubs.jamanetwork.com/article.aspx?articleID=2212255
Wed, 08 Apr 2015 00:00:00 GMTMiller AH, Raison CL. <span class="paragraphSection">This Viewpoint reports on the accumulating data indicating that inflammation may play a role in a host of psychiatric illnesses.</span>10.1001/jamapsychiatry.2015.22http://pubs.jamanetwork.com/article.aspx?articleID=2212255Comparison of Dermatology and Allergy Guidelines for Atopic Dermatitis Managementhttp://pubs.jamanetwork.com/article.aspx?articleID=2214161
Wed, 08 Apr 2015 00:00:00 GMTMohan GC, Lio PA. <span class="paragraphSection"><div class="boxTitle">Importance</div>Atopic dermatitis (AD) is a common skin condition treated by dermatologists, allergists, pediatricians, and primary care physicians. Several treatment guidelines and therapeutic parameters exist for the management of this disease. Health care professionals may be unaware of guidelines created by specialty organizations other than their own.<div class="boxTitle">Objective</div>To review, compare, and contrast the most recent AD management guidelines.<div class="boxTitle">Evidence Review</div>The guidelines for AD management published by the American Academy of Dermatology 2014 work group were compared with those created by the 2012 Joint Task Force on Practice Parameters representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology. International guidelines created by the 2012 European Task Force on Atopic Dermatitis and the 2013 Asia–Pacific Consensus Group for Atopic Dermatitis were also considered.<div class="boxTitle">Findings</div>Several differences among the guidelines suggest that there may be disparity in the perceptions of AD between US dermatologists and allergists and health care professionals in other areas of the world. There are notable differences among the guidelines regarding the recommendations for the use of diluted bleach baths, vitamin D, and environmental modifications.<div class="boxTitle">Conclusions and Relevance</div>Comparison of different guidelines may ultimately augment knowledge of treatment strategies and enhance realization of biases in the understanding and management of AD.</span>10.1001/jamadermatol.2015.0250http://pubs.jamanetwork.com/article.aspx?articleID=2214161